Home › Funds › THRIVENT FINANCIAL FOR LUTHERANS › LH

THRIVENT FINANCIAL FOR LUTHERANS position in LH

LABCORP HOLDINGS INC · Health Care

THRIVENT FINANCIAL FOR LUTHERANS reported holding 705,955 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$217.5M, representing 0.36% of its reported portfolio and ranking #43 among its reported holdings. THRIVENT FINANCIAL FOR LUTHERANS has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)705.96K sh
Reported value held$217.51M
Portfolio Weight0.36%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How THRIVENT FINANCIAL FOR LUTHERANS's LH position evolved

THRIVENT FINANCIAL FOR LUTHERANS first disclosed a stake in LH in Q3 2023 at 778,341 shares (US$156.5M). The position peaked in Q3 2026 at 705,955 shares, worth US$217.5M. Across 13 filings, THRIVENT FINANCIAL FOR LUTHERANS increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 705,955 shares valued at US$217.5M — a reduction of -6,345 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2024 (shares rose 1% over the following quarter), a 26% increase in Q2 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 778.34K $156.49M New
Q4 2023 779.16K $177.10M Hold
Q1 2024 853.01K $186.35M Add
Q2 2024 823.21K $167.53M Reduce
Q3 2024 749.27K $167.45M Reduce
Q4 2024 402.96K $92.41M Reduce
Q1 2025 411.94K $95.88M Add
Q2 2025 517.40K $135.82M Add
Q3 2025 563.01K $161.62M Add
Q4 2025 577.03K $144.76M Add
Q1 2026 701.64K $187.20M Add
Q2 2026 712.30K $199.44M Add
Q3 2026 705.96K $217.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 26 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has THRIVENT FINANCIAL FOR LUTHERANS held LH?

THRIVENT FINANCIAL FOR LUTHERANS has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is THRIVENT FINANCIAL FOR LUTHERANS's current position in LH?

As of Q3 2026, THRIVENT FINANCIAL FOR LUTHERANS holds 705.96K shares of LH (LABCORP HOLDINGS INC), valued at $217.51M, representing 0.36% of its reported portfolio and ranking #43.

Has THRIVENT FINANCIAL FOR LUTHERANS been buying or selling LH?

In the latest 13F filing (Q3 2026), THRIVENT FINANCIAL FOR LUTHERANS reduced its position in LH. The position peaked in Q3 2026 at 705.96K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.